Biotech is our opening topic this morning as we deep dive into a double announcement from EQT. The firm is acquiring a Swedish biotech company as part of the launch of a new Healthcare Growth Strategy ...
BOSTON and STOCKHOLM, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated Contract ...
STOCKHOLM and BOSTON, March 18, 2026 /PRNewswire/ -- Mabtech, a Swedish life science tools company specializing in high-quality immunoassays, reagents, and instrumentation, today announced a strategic ...
(RTTNews) - EQT (EQT) introduced the EQT Healthcare Growth Strategy, a dedicated healthcare buyout strategy. The strategy aims to enable the development of medical research, diagnostics, tools and ...
EQT has announced the acquisition of Swedish biotech company Mabtech in what partner Isabel de Paoli told PE Hub Europe was a “perfect fit” for the private equity firm’s new Healthcare Growth Strategy ...
Sai Life Sciences' Boston site designated as co-marketed U.S. execution hub for Mabtech's EYRA platform, bringing high-sensitivity multiplex immune profiling to biopharma and biotech clients across ...
Mabtech, a global life science tools company specializing in advanced immunoassays, and Sai Life Sciences, a leading integrated contract research, development, and manufacturing organization (CRDMO), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results